Steel Forest, LLC | AbbVie | New York | local | 2017 | $275,871 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | Local | 2018 | $206,943 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2020 | $326,753 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2021 | $261,116 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2022 | $264,555 | | tax credit/rebate |
St. Jude Medical Cardiology Division, Inc. | Abbott Laboratories | South Carolina | state | 2018 | undisclosed | | tax credit/rebate |
St. Jude Medical | Abbott Laboratories | South Carolina | state | 2006 | undisclosed | | tax credit/rebate |
ST. JUDE MEDICAL | Abbott Laboratories | South Carolina | state | 2009 | $59,305 | | training reimbursement |
St. Jude Medical | Abbott Laboratories | Minnesota | state | 2022 | undisclosed | | sales tax exemption |
Sprout Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2013 | $5,646 | | tax credit/rebate |
Sprout Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2016 | $2,940 | | tax credit/rebate |
Sprout Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2015 | $3,313 | | tax credit/rebate |
Spark Therapeutics, LLC | Roche | Pennsylvania | state | 2017 | $790,740 | | tax credit/rebate |
SPARK THERAPEUTICS, LLC | Roche | Pennsylvania | state | 2020 | $1,687,300 | | tax credit/rebate |
Spark Therapeutics, Inc. | Roche | Pennsylvania | state | 2019 | $2,000,000 | | grant |
Spark Therapeutics Inc | Roche | Pennsylvania | state | | $150,000 | | grant |
Spark Therapeutics Inc | Roche | Pennsylvania | state | | $201,000 | | tax credit/rebate |
Spark Therapeutics Inc | Roche | Pennsylvania | state | 2014 | $201,000 | | tax credit/rebate |
Spark Therapeutics Inc | Roche | Pennsylvania | state | 2014 | $150,000 | | grant |
SmithKline Beecham Corporation DBA GlaxoSmithKline | GlaxoSmithKline | Pennsylvania | state | 2008 | $2,990,917 | | tax credit/rebate |
SmithKline Beecham Corporation DBA GlaxoSmithKline | GlaxoSmithKline | Pennsylvania | state | 2010 | $435,635 | | tax credit/rebate |
SmithKline Beecham Corporation DBA GlaxoSmithKline | GlaxoSmithKline | Pennsylvania | state | 2011 | $951,581 | | tax credit/rebate |
Silarx Pharmaceuticals, Inc. | Lannett Co. | New York | state | 2015 | $952,757 | | tax credit/rebate |
Silarx Pharmaceuticals, Inc | Lannett Co. | United States | federal | 2012 | | $2,138,000 | federal loan or loan guarantee |
SIGMA-ALDRICH CORPORATION | Merck KGaA (EMD) | Missouri | state | 2000 | $9,064 | | tax credit/rebate |
SIGMA-ALDRICH CORPORATION | Merck KGaA (EMD) | Missouri | state | 2000 | $32,392 | | tax credit/rebate |
Sigma-Aldrich Corporation | Merck KGaA (EMD) | Wisconsin | state | 2017 | $1,250,000 | | tax credit/rebate |
SIGMA-ALDRICH CO. LLC | Merck KGaA (EMD) | Missouri | state | 2011 | $100,000 | | tax credit/rebate |
SIGMA-ALDRICH BIOTECHNOLOGY L.P. | Merck KGaA (EMD) | Missouri | state | 2001 | $12,298,727 | | tax credit/rebate |
Shire ViroPharma, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2016 | $85,794 | | tax credit/rebate |
Shire ViroPharma Incorporated | Takeda Pharmaceutical | Pennsylvania | state | 2015 | $312,596 | | tax credit/rebate |
Shire US Manufacturing, Inc. | Takeda Pharmaceutical | Maryland | state | 2004 | $26,595 | | training reimbursement |
Shire US Manufacturing, Inc. | Takeda Pharmaceutical | Maryland | state | 2008 | $24,791 | | training reimbursement |
Shire US Manufacturing, Inc. | Takeda Pharmaceutical | Maryland | state | 2009 | $30,126 | | tax credit/rebate |
Shire US Manufacturing Inc. | Takeda Pharmaceutical | Maryland | state | 2007 | $23,191 | | training reimbursement |
Shire US Holdings, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2013 | $255,775 | | tax credit/rebate |
Shire US Holdings, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2014 | $914,646 | | tax credit/rebate |
Shire Pharmaceuticals, Inc. | Takeda Pharmaceutical | Pennsylvania | state | | $1,200,000 | | tax credit/rebate |
Shire Pharmaceuticals, Inc. | Takeda Pharmaceutical | Pennsylvania | state | | $2,000,000 | | grant |
Shire Pharmaceuticals, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2009 | $246,912 | | tax credit/rebate |
Shire Pharmaceuticals, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2010 | $228,422 | | tax credit/rebate |
Shire Pharmaceuticals Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2008 | $402,051 | | tax credit/rebate |
Shire Human Genetics Therapies, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2007 | undisclosed | | tax credit/rebate |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2013 | $750,000 | | tax credit/rebate |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2015 | $85,593 | | tax credit/rebate |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2016 | $118,253 | | tax credit/rebate |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2017 | $160,094 | | tax credit/rebate |
Shire Human Genetic Therapies, Inc | Takeda Pharmaceutical | Massachusetts | state | 2012 | $3,000,000 | | tax credit/rebate |
SHIRE HUMAN GENETIC THERAPIES INC | Takeda Pharmaceutical | Pennsylvania | state | 2020 | $121,300 | | tax credit/rebate |
Shire Human Genetic Therapies Inc | Takeda Pharmaceutical | Pennsylvania | state | 2021 | $294,400 | | tax credit/rebate |
Shire Human Genetic Therapies | Takeda Pharmaceutical | Massachusetts | state | 2014 | $597,076 | | tax credit/rebate |
Shire Human Genetic Therapies | Takeda Pharmaceutical | Massachusetts | state | 2015 | $985,000 | | tax credit/rebate |
Shire Holdings US, AG | Takeda Pharmaceutical | Maryland | state | 2004 | $588,423 | | tax credit/rebate |
Shire Holdings US, AG | Takeda Pharmaceutical | Maryland | state | 2005 | $53,032 | | tax credit/rebate |
Shire Holdings US, AG | Takeda Pharmaceutical | Pennsylvania | state | 2015 | $1,223,167 | | tax credit/rebate |
Shire Holdings US, AG | Takeda Pharmaceutical | Pennsylvania | state | 2016 | $621,710 | | tax credit/rebate |
Shire Holdings US AG | Takeda Pharmaceutical | Maryland | state | 2007 | $27,738 | | tax credit/rebate |
Shire Holding US AG | Takeda Pharmaceutical | Maryland | state | 2008 | $33,609 | | tax credit/rebate |
Shire HGT, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2011 | $5,855,368 | | tax credit/rebate |
Shire HGT, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2011 | $3,500,000 | | tax credit/rebate |
Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2004 | $2,732 | | tax credit/rebate |
Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2005 | $1,205 | | tax credit/rebate |
Serono Labs | Merck KGaA (EMD) | Massachusetts | state | 2001 | undisclosed | | tax credit/rebate |
Serenex, Inc. | Pfizer | North Carolina | state | 2011 | $21,743 | | tax credit/rebate |
Serenex, Inc. | Pfizer | North Carolina | state | 2010 | $21,507 | | tax credit/rebate |
SEATTLE GENETICS, INC. | Seattle Genetics Inc. | Washington | state | 2017 | $1,515,773 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2004 | $85,688 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2005 | $141,146 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2006 | $64,881 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2007 | $425,295 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2008 | $239,698 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2009 | $543,597 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2010 | $131,488 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2011 | $18,072 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2011 | $51,253 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2004 | $40,481 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2006 | $156,516 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2008 | $156,516 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2009 | $156,516 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2010 | $51,253 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2012 | $19,023 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2012 | $13,467 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2013 | $13,467 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2013 | $17,655 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2014 | $13,522 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2014 | $185,655 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2015 | $13,467 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2016 | $189,472 | | tax credit/rebate |
Schering-Plough Animal Health Corporation | Merck | Delaware | state | 2006 | $21,485 | | training reimbursement |
Schering-Plough Animal Health Corporation | Merck | Delaware | state | 2007 | $43,943 | | training reimbursement |
Schering-Plough Animal Health Corporation | Merck | Delaware | state | 2008 | $45,400 | | training reimbursement |
Schering Corporation | Merck | Florida | state | 2007 | $84,000 | | tax credit/rebate |
SANOFI-AVENTIS US LLC | Sanofi | Washington | state | 2015 | $70,422 | | tax credit/rebate |
SANOFI-AVENTIS US LLC | Sanofi | Washington | state | 2016 | $70,422 | | tax credit/rebate |
Sanofi-Aventis U.S. LLC and Sanofi-Aventis U.S. In | Sanofi | New Jersey | state | 1997 | $2,784,000 | | grant |
Sanofi-Aventis U.S. LLC and Sanofi-Aventis U.S. In | Sanofi | New Jersey | state | 1999 | $21,795,200 | | grant |
Sanofi-Aventis U.S. LLC and Sanofi-Aventis U.S. | Sanofi | New Jersey | state | 2005 | $8,369,000 | | grant |
Sanofi-Aventis | Sanofi | Massachusetts | state | 2011 | $2,450,000 | | tax credit/rebate |
Sanofi US Services, Inc. | Sanofi | Pennsylvania | state | 2014 | $314,989 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2009 | $154,593 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2010 | $78,092 | | tax credit/rebate |